IShares Biotechnology ETF Forward View - Simple Moving Average
| IBB ETF | USD 167.87 -1.15 -0.68% |
The Simple Moving Average output for iShares Biotechnology ETF is derived from daily price data across the evaluation window. The error pattern reveals whether the model tracked prices consistently or diverged during volatile sessions. Parameters are re-estimated as new trading sessions are recorded, keeping the forecast current. The Simple Moving Average model projects IShares Biotechnology at 168.44 for the next trading day, above the most recent closing price. IShares Biotechnology's Simple Moving Average forecast is intended for short-term analytical reference.
Simple Moving Average Price Forecast For the 29th of April
Over a 90-day horizon, the Simple Moving Average model forecasts IShares Biotechnology at 168.44 for the next trading day, with a mean absolute deviation of 2.03 , mean absolute percentage error of 0.01 , and sum of absolute errors of 119.84 .This represents a very tight forecast — the model closely tracks IShares Biotechnology's recent price behavior. This output is intended for short-term analytical reference.
ETF Forecast Pattern
| Backtest IShares Biotechnology | IShares Biotechnology Price Prediction | Research Analysis |
Forecasted Value
The projected range for IShares Biotechnology reflects the model's ability to define credible downside and upside scenarios for the next trading day. The current forecast range spans downside near 167.05 and upside near 169.83. The narrow range indicates limited short-term dispersion.
Model Predictive Factors
The table below summarizes the Simple Moving Average model's error metrics for IShares Biotechnology ETF. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 116.3093 |
| Bias | Arithmetic mean of the errors | 0.1319 |
| MAD | Mean absolute deviation | 2.0313 |
| MAPE | Mean absolute percentage error | 0.012 |
| SAE | Sum of the absolute errors | 119.845 |
Other Forecasting Options for IShares Biotechnology
Relative Strength Index values for IShares measure the speed and magnitude of recent price changes. Recognizing these clusters in IShares Biotechnology's returns informs position size and stop-loss calibration. Candlestick pattern analysis of IShares ETF daily data reveals short-term reversal or continuation signals.IShares Biotechnology Related Equities
The peer firms below within the Health space frame IShares Biotechnology's pricing and running costs in context. Looking at IShares Biotechnology's pricing multiples next to these peers shows if the stock trades at a premium or discount. Falling behind peers on key ratios may signal headwinds or execution issues worth looking into.
| Risk & Return | Correlation |
IShares Biotechnology Market Strength Events
Accumulation/Distribution and Balance of Power for IShares Biotechnology reveal whether buying or selling pressure dominates recent sessions. Balance of Power trending positive indicates that buyers are consistently closing IShares Biotechnology near session highs. These signals help explain whether price direction and session structure are moving together for IShares Biotechnology.
| Accumulation Distribution | 18109.57 | |||
| Daily Balance Of Power | -0.35 | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 169.16 | |||
| Day Typical Price | 168.73 | |||
| Price Action Indicator | -1.86 | |||
| Period Momentum Indicator | -1.15 |
IShares Biotechnology Risk Indicators
Risk indicator analysis for IShares Biotechnology quantifies how much price variability the ETF has exhibited over the measurement window. Downside variance exceeding total variance indicates that negative moves in IShares Biotechnology have been larger or more frequent than positive ones. Mean deviation provides a more intuitive measure of typical price fluctuation than variance because it stays in the same units as IShares Biotechnology's price.
| Mean Deviation | 1.06 | |||
| Standard Deviation | 1.38 | |||
| Variance | 1.91 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.